Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Shares Issued (2016 - 2025)

Ultralife (ULBI) has 14 years of Shares Issued data on record, last reported at $37000.0 in Q3 2025.

  • For Q3 2025, Shares Issued rose 54.17% year-over-year to $37000.0; the TTM value through Sep 2025 reached $137000.0, down 95.12%, while the annual FY2024 figure was $2.0 million, 60.18% up from the prior year.
  • Shares Issued reached $37000.0 in Q3 2025 per ULBI's latest filing, down from $61000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $1.3 million in Q2 2024 and bottomed at $24000.0 in Q3 2024.
  • Average Shares Issued over 4 years is $393090.9, with a median of $84000.0 recorded in 2021.
  • Peak YoY movement for Shares Issued: soared 502.13% in 2021, then tumbled 97.55% in 2024.
  • A 4-year view of Shares Issued shows it stood at $84000.0 in 2021, then surged by 911.9% to $850000.0 in 2023, then crashed by 95.41% to $39000.0 in 2024, then decreased by 5.13% to $37000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $37000.0 in Q3 2025, $61000.0 in Q2 2025, and $39000.0 in Q4 2024.